Study of DHPS and DHFR genes of Pneumocystis jirovecii in Thai HIV-infected patients

References

• Hughes WT. Prevention and treatment of Pneumocystis carinii pneumonia. Ann Rev Med 1991; 42: 287–295
   Google Scholar
• Fishman JA. Prevention of infection due to Pneumocystis carinii. Antimicrob Agents Chemother 1998; 42: 995–1004
   PubMed Web of Science ®Google Scholar
• Klein NC, Duncanson FP, Lenox TH, et al. Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients: results of a large prospective randomized treatment trial. AIDS 1992; 6: 301–305
   PubMed Web of Science ®Google Scholar
• Hardy WD, Feinberg J, Finkelstein DM, et al. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. N Engl J Med 1992; 327: 1842–1848
   PubMed Web of Science ®Google Scholar
• Bozzette SA, Finkelstein DM, Spector SA, et al. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med 1995; 332: 693–699
   PubMed Web of Science ®Google Scholar
• Saah AJ, Hoover DR, Peng Y, et al. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS cohort study. JAMA 1995; 273: 1197–1202
   PubMedGoogle Scholar
• Bonora S, Di Perri G, Vento S, Cazzadori A, Concia E. Failure of prophylaxis against PCP in patients with HIV infection. AIDS Patient Care STDS 1998; 12: 843–848
   Google Scholar
• Ma L, Borio L, Masur H, Kovacs JA. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use. J Infect Dis 1999; 180: 1969–1978
   PubMed Web of Science ®Google Scholar
• Takahashi T, Endo T, Nakamura T, et al. Dihydrofolate reductase gene polymorphisms in Pneumocystis carinii f. sp. hominis in Japan. J Med Microbiol 2002; 51: 510–515
   Google Scholar
• Siripattanapipong S, Worapong J, Mungthin M, Leelayoova S, Tan-ariya P. Genotypic study of Pneumocystis jirovecii in human immunodeficiency virus-positive patients in Thailand. J Clin Microbiol 2005; 43: 2104–2110
   PubMed Web of Science ®Google Scholar
• Takahashi T, Hosoya N, Endo T, et al. Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy. J Clin Microbiol 2000; 38: 3161–3164
   PubMed Web of Science ®Google Scholar
• Kazanjian P, Locke AB, Hossler PA, et al. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients. AIDS 1998; 12: 873–878
   PubMed Web of Science ®Google Scholar
• Lane BR, Ast JC, Hossler PA, et al. Dihydropteroate synthase polymorphisms in Pneumocystis carinii. J Infect Dis 1997; 175: 482–485
   PubMed Web of Science ®Google Scholar
• Totet A, Latouche S, Lacube P, et al. Pneumocystis jirovecii dihydropteroate synthase genotypes in immunocompetent infants and immunosuppressed adults, Amiens, France. Emerg Infect Dis 2004; 10: 667–673
   PubMedGoogle Scholar
• Higgins DG, Thompson JD, Gibson TJ. Using CLUSTAL for multiple sequence alignments. Methods Enzymol 1996; 266: 383–402
   PubMed Web of Science ®Google Scholar
• Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997; 25: 4876–4882
   PubMed Web of Science ®Google Scholar
• Nahimana A, Rabodonirina M, Bille J, Francioli P, Hauser PM. Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis. Antimicrob Agents Chemother 2004; 48: 4301–4305
   PubMed Web of Science ®Google Scholar
• Robberts FJ, Chalkley LJ, Weyer K, Goussard P, Liebowitz LD. Dihydropteroate synthase and novel dihydrofolate reductase gene mutations in strains of Pneumocystis jirovecii from South Africa. J Clin Microbiol 2005; 43: 1443–1444
   PubMedGoogle Scholar
• Costa MC, Esteves F, Antunes F, Matos O. Genetic characterization of the dihydrofolate reductase gene of Pneumocystis jirovecii isolates from Portugal. J Antimicrob Chemother 2006; 58: 1246–1249
   PubMedGoogle Scholar
• Kazanjian P, Armstrong W, Hossler PA, et al. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J Infect Dis 2000; 182: 551–557
   PubMed Web of Science ®Google Scholar
• Navin TR, Beard CB, Huang L, et al. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P. carinii pneumonia in patients with HIV-1: a prospective study. Lancet 2001; 358: 545–549
   PubMed Web of Science ®Google Scholar
• Huang L, Beard CB, Creasman J, et al. Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. J Infect Dis 2000; 182: 1192–1198
   PubMed Web of Science ®Google Scholar
• Helweg-Larsen J, Benfield TL, Eugen-Olsen J, Lundgren JD, Lundgren B. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet 1999; 354: 1347–1351
   PubMed Web of Science ®Google Scholar
• Visconti E, Ortona E, Mencarini P, et al. Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia. Int J Antimicrob Agents 2001; 18: 547–551
   PubMed Web of Science ®Google Scholar
• Nahimana A, Rabodonirina M, Zanetti G, et al. Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus-positive and -negative patients. J Infect Dis 2003; 188: 1017–1023
   PubMed Web of Science ®Google Scholar
• Ma L, Kovacs JA, Cargnel A, et al. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis. J Infect Dis 2002; 185: 1530–1532
   PubMed Web of Science ®Google Scholar